Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Othman Metwally"'
Autor:
Hilal Al-Sabti, Ali T. Al-Hinai, Ibrahim Al-Zakwani, Khamis Al-Hashmi, Wael Al Mahmeed, Mohamed Arafah, Abdullah Shehab, Omer Al Tamimi, Mahmoud Al Awadhi, Shorook Al Herz, Faisal Al Anazi, Khalid Al Nemer, Othman Metwally, Akram Alkhadra, Mohammed Fakhry, Hossam Elghetany, Abdel Razak Medani, Afzal Hussein Yusufali, Obaid Al Jassim, Omar Al Hallaq, Fahad Omar Ahmed S. Baslaib, Haitham Amin, Khalid Al-Waili, Khalid Al-Rasadi
Publikováno v:
Oman Medical Journal, Vol 37, Iss 2, Pp e367-e367 (2022)
Objectives: We sought to estimate the percentage achievements of non-high-density lipoprotein cholesterol (non-HDL-C) target in patients with very high atherosclerotic cardiovascular diseases (ASCVD) risk stratified by triglyceride (TG) levels despit
Externí odkaz:
https://doaj.org/article/ad23183742bc4b38b2978450d75ef0d9
Autor:
Akram Al-Khadra, Mohamed Arafah, Haitham Amin, Faisal Al Anazi, Othman Metwally, Abdel Razak Medani, Abdullah Shehab, Obaid Al Jassim, Afzalhussein Yusufali, Akshaya Srikanth Bhagavathula, Mahmoud Alawadhi, Ali T. Al-Hinai, Khalid Al-Rasadi, Omar Al Hallaq, Khalid Al Nemer, Khamis Al-Hashmi, Mohammed Fakhry, Abderrahim Oulhaj, Shorook Al Herz, Hossam Elghetany, Fahad Omar Baslaib, Wael Al Mahmeed, Omer Al Tamimi
Publikováno v:
Current Vascular Pharmacology. 16:368-375
Background: Dyslipidaemia is a risk factor for macrovascular complications in patients with type 2 diabetes mellitus (T2DM). Our aim was to assess the use of lipid lowering drugs (LLDs) in patients with T2DM and co-existing dyslipidaemia. Method: A m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3553a3bc75d7a240dcc86e597765d978
https://doi.org/10.2174/1570161115666170705153815
https://doi.org/10.2174/1570161115666170705153815
Autor:
Mohammed Fakhry, Shorook Al Herz, Faisal Al Anazi, Wael Al Mahmeed, Khalid Al Nemer, Ali T. Al-Hinai, Omar Al Hallaq, Obaid Al Jassim, Khalid Al Rasadi, Omer Al Tamimi, Akram Al-Khadra, Hossam Elghetany, Khalid Al Waili, Vasilios G. Athyros, Khamis Al Hashmi, Abdel Razak Medani, Othman Metwally, Ibrahim Al-Zakwani, Fahad Omar, Mohamed Arafah, Ahmed S Baslaib, Haitham Amin, Abdullah Shehab, Afzalhussein Yusufali, Mahmoud Al Awadhi
Publikováno v:
Current Vascular Pharmacology. 15:51-58
Background: Few studies assessed gender disparity in lipid goal attainment in the Arabian Gulf. Hence, we estimated gender gaps in lipid target achievements among patients at high and very high atherosclerotic cardiovascular disease (ASCVD) risk in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5586a252cac0cf891bb1a9b5cf3db074
https://doi.org/10.2174/1570161114666161003095139
https://doi.org/10.2174/1570161114666161003095139
Autor:
Khalid Al-Rasadi, Abdel Razak Medani, Abdullah Shehab, Hossam Elghetany, Othman Metwally, Mohammed Fakhry, Afzal Yusufali, Mahmoud Alawadhi, Fahad Omar Baslaib, Omer Al-Tamimi, Omar Al-Hallaq, Ali T. Al-Hinai, Khalid Alnemer, Ibrahim Al-Zakwani, Obaid Aljassim, Mohamed Arafah, Wael Almahmeed, Raul D. Santos, Haitham Amin, Khamis Al-Hashmi, Khalid Al-Waili, Faisal Al-Anazi, Akram Al-Khadra, Shorook Al-Herz
Publikováno v:
Scopus-Elsevier
Current Vascular Pharmacology
Current Vascular Pharmacology
We evaluated the control of cardiovascular disease (CVD) risk factors among patients with atherosclerotic cardiovascular disease (ASCVD) in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolaemia (CEPHEUS) in the Arabian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d67e25c528e1f2a0bb2044bd0525282
https://doi.org/10.2174/1570161113666151026115921
https://doi.org/10.2174/1570161113666151026115921
Autor:
Ibrahim Al-Zakwani, Abdel Razak Medani, Mohammed Arafah, Mohammed Fakhry, Obaid Al Jassim, Khalid Al-Rasadi, Hossam Elghetany, Abdullah Shehab, Shorook Al Herz, Ali T. Al-Hinai, Omer Al Tamimi, Faisal Al Anazi, Fahad Omar Baslaib, Afzalhussein Yusufali, Raul D. Santos, Wael Al Mahmeed, Mahmoud Al Awadhi, Khamis Al-Hashmi, Akram Al-Khadra, Khalid Al Nemer, Haitham Amin, Othman Metwally, Omar Al Hallaq, Khalid Al-Waili
Publikováno v:
Journal of Clinical Lipidology. 10(2):368-377
BackgroundAtherogenic dyslipidemia is highly prevalent in the Arabian Gulf. Non–high-density lipoprotein cholesterol (non-HDL-C) reduction has been proposed as an additional goal to low-density lipoprotein cholesterol (LDL-C) lowering to prevent at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a99b6db995d7089dd92373ab440483
Autor:
Omer Al Tamimi, Mohammed Fakhry, Mahmoud Alawadhi, Haitham Amin, Khalid Al Nemer, Shorook Al Herz, Hossam Elghetany, Faisal Al Anazi, Othman Metwally, Khalid Al-Rasadi, Abdullah Shehab, Abdel Razak Medani, Omar Al Hallaq, Akram Al-Khadra, Mohamed Arafah, Afzalhussein Yusufali, Ali T. Al-Hinai, Obaid Al Jassim, Khamis Al-Hashmi, Fahad Omar Baslaib, Wael Al Mahmeed
Publikováno v:
Angiology. 65(10)
The Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS) survey evaluated the attainment of low-density lipoprotein cholesterol (LDL-C) goals among patients on lipid-lowering drugs (LLDs) according to the updated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6632631f68d4db52c58c55be4af6fb4d
https://pubmed.ncbi.nlm.nih.gov/24301426
https://pubmed.ncbi.nlm.nih.gov/24301426
Autor:
Raul D. Santos, Khalid Al-Waili, Khamis Al-Hashmi, Afzalhussein Yusufali, Mohammed Fakhry, Faisal Al Anazi, Khalid Al-Rasadi, Othman Metwally, Abdullah Shehab, Mahmoud Al Awadhi, Obaid Al Jassim, Ibrahim Al-Zakwani, Mohamed Arafah, Khalid Al Nemer, Ali T. Al-Hinai, Omar Al Hallaq, Haitham Amin, Akram Al-Khadra, Hossam Elghetany, Fahad Omar Baslaib, Wael Al Mahmeed, Omer Al Tamimi, Shorook Al Herz, Abdel Razak Medani
Publikováno v:
Diabetology & Metabolic Syndrome
Background The aim of this study was to determine the impact of metabolic syndrome (MetS) on lipid target achievements in the Arabian Gulf. Methods The centralized pan-middle east survey on the undertreatment of hypercholesterolemia (CEPHEUS) include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f756ee5e5e35ff80c7dc879687a9726a